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Introduction 
Posttraumatic stress disorder (PTSD) can 
occur after witnessing or experiencing a 
terrifying event (Mayo Clinic, 2015).  PTSD 
can manifest in a variety of symptoms 
including, nightmares, flashbacks, 
insomnia, irritability, and anger (Mayo 
Clinic, 2015).  The extended combat 
engagement in Afghanistan and Iraq have 
caused many casualties for American 
service members, both physically and 
mentally.  The Veterans Affairs (VA) stated 
that 476,515 people sought treatment for 
PTSD in 2011 alone (Veteran Affairs, 
2014).  
The veterans returning home from combat 
require adequate services to support their 
transition to civilian life.  Barriers may 
exist for those members with PTSD 
symptoms seeking treatment.  The 
healthcare system must have an 
understanding of the unique set of 
psychological problems that veterans face 
to provide proper treatment.  The 
disparity that exists between PTSD 
patients and treatment is a gap worth 
closing.  The lack of identification of 
symptoms, availability of treatment, and 
overall failure to support veterans in need 
can have drastic results.  A large 
population of the country knows of a 
veteran that has served in combat, or has 
served themselves.  The author served as 
a United States Marine deployed in 
combat and also has family currently 
battling with PTSD and other psychiatric 
issues related to experiences in war.  The 
treatment of veterans and others with 
psychiatric conditions, can be related by 
nursing staff in many different specialties.  
The acute psychosis seen in the 
emergency department or the 
overwhelming depression in the long term 
care facilities should be treated 
appropriately.  Patient care will improve 
when healthcare providers and workers 
have a more knowledgeable 
understanding of PTSD.  
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Underlying 
Pathophysiology 
A definite pathophysiological cause for 
PTSD is not known at this time.  There is 
an increasing amount of research that 
suggests PTSD is associated with the 
chronic increase of central nervous 
system circuits that utilize corticotropin 
releasing hormone (CRH) (Dunlop et al., 
2014).  During a stress response the CRH 
level increases which activates the 
hypothalamic-pituitary-adrenal (HPA) 
axis thus releasing cortisol and other 
adrenal steroids (Dunlop et al., 2014).  
These are the same type of hormones 
associated with the adrenaline surge 
during the fight or flight response. 
Increased activity of CRH containing 
neurons in the amygdala are known to 
activate fear related behaviors, while 
neocortical CRH can reduce the 
expectation of rewards (Dunlop et al., 
2014).  CRH release produces anxiety-like 
behavior consistant with PTSD such as 
sleep disturbance, enhanced acoustic 
startle response, and increased 
conditioned fear response (Dunlop et al., 
2014). 
     Another body of research suggests 
that pituitary adenylate cyclase-
activating polypeptide (PACAP) has a role 
in PTSD and other human stress 
responses (Ressler, Mercer, Bradley, 
Jovanovic, Mahan, Kerley, Norrholm, 
Kilaru, Smith, Myers, Ramirez, Engel, 
Hammack, Toufexis, Braas, Binder & 
May, 2011). PACAP functions in 
development, cell signaling, metabolism, 
homeostasis, and cell protection as well 
as regulation of CRH (Ressler et al., 
2011).  Increased blood levels of PACAP 
have been associated with the diagnosis 
of PTSD during two separate but similar 
studies (Ressler et al., 2011).  The levels 
of PACAP were found to correlate 
directly to the differential response of 
avoidance, intrusive re-experience, and 
hyperarousal in the subjects of the study 
(Ressler et al., 2011).  PACAP continues 
to be related to cellular stress response 
since identification more than 20 years 
ago (Ressler et al., 2011).  The complete 
role of the PACAP system in behavioral 
stress response is yet to be discovered 
(Ressler et al., 2011).  The 
pathophysiology of PTSD is complicated 
with a variety of contributing factors.  
Advances in the research will enable 
providers and patients to deal with the 
devastating effects of the condition.   
Signs and Symptoms 
PTSD is the chronic anxiety disorder that 
follows exposure to an overwhelming 
traumatic event (Dunlop, Rothbaum, 
Binder, Duncan, Harvey, Jovanovic, Kelley, 
Kinkead, Kutner, Iosifescu, Mathew, 
Neylan, Kilts, Nemeroff & Mayberg, 2014).  
PTSD is historically linked with combat 
veterans, but can also manifest in patients 
that experience other types of traumatic 
events (Warner, Warner, Appenzeller & 
Hoge, 2013).  Recognizing the presentation 
of PTSD in a patient is an important 
element in developing an evidence based 
treatment plan.  PTSD develops with four 
main symptoms; re-experiencing the event 
or intrusion, avoidance of people, places, 
or things that elicit the memory, negative 
mood changes and thoughts associated 
with the event, and chronic hyperarousal 
symptoms (Warner et al., 2013).  
Distinction between PTSD and other 
psychiatric conditions can be made based 
on the symptoms and duration.  Acute 
stress disorder has similar symptoms to 
PTSD but includes dissociation and is 
limited to one month duration (Warner et 
al., 2013).  The Diagnostic and Statistical 
Manual of Mental Disorders (DSM) 
previously required the patient to have a 
sense of helplessness during the traumatic 
event to diagnosis PTSD (Warner et al., 
2013).  The DSM responded to the recent 
evidence that military members and first 
responders did not report signs of 
helplessness when they experienced 
traumatic events (Warner et al., 2013).  
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Significance of 
Pathophysiology 
The full pathophysiology of PTSD is not 
completely understood at this time.  There 
is ongoing research, both privately and 
publicly funded, to gain more insight on the 
disorder.  The Iraq and Afghanistan wars 
have brought the disorder to the forefront 
due to the overwhelming number of 
veterans who suffer the effects.  The bodies 
physiological response to PTSD is better 
understood than the pathophysiology of the 
actual disorder.  A recent study found a link 
between combat veterans with PTSD and 
the diagnosis of hypertension (Paulus, Argo 
& Egge, 2013).  The PTSD subject group had 
similar percentages of smoking and 
substance abuse as the non-PTSD group, yet 
they had much higher rate of hypertension 
and increased resting heart rate (Paulus et 
al., 2013).  Evidence has suggested that 
norepinephrine, which is chronically 
elevated in PTSD, has led to structural and 
functional changes in the cardiovascular 
system as expressed by an increase in heart 
rate and blood pressure (Paulus et al., 
2013).   
      A study was conducted of 109 veterans 
with PTSD which revealed a majority of the 
subjects met the criteria for bipolar disorder 
(BPD) utilizing the Mini International 
Neuropsychiatric Interview (MINI) (McLay, 
Ram, Webb-Murphy, Baird, Hickey & 
Johnston, 2014).  The study was concerning 
because a diagnosis of BPD would prevent a 
person from entering military service which 
would suggest the men developed BPD 
while in service.  The authors of the study 
were quick to point out that, upon 
reassessment at follow up appointments, all 
subjects were found to be free of BPD 
(McLay et al., 2014).  This finding should 
challenge the method of assessing patients 
for mental illness, especially those with 
preexisting PTSD.  The study suggests that 
patients with PTSD must be assessed 
differently to prevent over diagnosing a 
comorbid condition such as BPD (McLay et 
al., 2014). 
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The treatment modalities for PTSD can be 
tailored for the patient to manage 
individual symptoms.  The treatments may 
include pharmacological, psychotherapy, 
yoga, and acupuncture (Warner et al., 
2013).  Studies have improved the 
pharmacological treatment of PTSD.  The 
U.S. Food and Drug Administration 
approved the use of sertraline and 
paroxetine for treatment of PTSD (Warner 
et al., 2013).  The use of selective serotonin 
reuptake inhibitors and serotonin-
norepinephrine reuptake inhibitors are 
considered first-line therapy for symptoms 
of PTSD (Warner et al., 2013).  Providers 
should know that the use of 
benzodiazepines will treat the hyperarousal 
symptoms but can exacerbate other 
symptoms (Warner et al., 2013).  The use of 
antihistamines and hypnotics such as 
Ambien or Sonata may be used in short 
durations to help with insomnia (Warner et 
al., 2013).  Mood stabilizers have mixed 
reviews in treatment of PTSD and should be 
used on a case by case basis according to 
studies (Warner et al., 2013).  The 
overwhelming evidence does show that 
antipsychotics are not recommended for 
treatment of PTSD.  The knowledge of 
proper pharmacology for the treatment of 
PTSD will benefit the provider and the 
patient alike.  The symptom management 
in PTSD can effectively prevent veteran 
suicide and promote regaining control over 
their physical and mental health.   
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